Literature DB >> 30715591

[Epidemiology of severe visual impairment and blindness of old people in Germany].

M M Mauschitz1,2, J Q Li1, P P Larsen1, J Köberlein-Neu3, F G Holz1, M M B Breteler2,4, R P Finger5.   

Abstract

Approximately 500,000 blind and 1 million visually impaired persons live in Germany, which lacks a national blind registry. Therefore data from social welfare agencies and population-based studies are used to estimate prevalence and incidence. Main causes for severe visual impairment and blindness are age-related macular degeneration, glaucoma and diabetic eye diseases. We observed a relative decline of the incidence of severe visual impairment and blindness over the last decades, which is primarily due to improved ophthalmic care and better treatment options. However, the absolute number of subjects with severe visual impairment and blindness increases due to population ageing. This will cause significant social and economic challenges in the future.

Entities:  

Keywords:  Age-related macular degeneration; Glaucoma; Incidence; Prevalence; Treatment needs

Mesh:

Year:  2019        PMID: 30715591     DOI: 10.1007/s00347-019-0853-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  26 in total

1.  Projection of Morbidity 2030 and 2050: Impact for the National Health System and Blood Supply.

Authors:  Alexander Katalinic; Elke Peters; Fritz Beske; Ron Pritzkuleit
Journal:  Transfus Med Hemother       Date:  2010-05-20       Impact factor: 3.747

2.  Is homelessness a risk factor for eye disease? Results of a German screening study.

Authors:  Susanne Pitz; Christina Kramann; Frank Krummenauer; Andreas Pitz; Gerhard Trabert; Norbert Pfeiffer
Journal:  Ophthalmologica       Date:  2005 Nov-Dec       Impact factor: 3.250

Review 3.  Medical versus surgical interventions for open angle glaucoma.

Authors:  J Burr; A Azuara-Blanco; A Avenell
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 4.  [Blindness in Germany--today and in 2030].

Authors:  C Knauer; N Pfeiffer
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

5.  Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008.

Authors:  C Bunce; W Xing; R Wormald
Journal:  Eye (Lond)       Date:  2010-09-17       Impact factor: 3.775

Review 6.  Are we blind to injuries in the visually impaired? A review of the literature.

Authors:  R Legood; P Scuffham; C Cryer
Journal:  Inj Prev       Date:  2002-06       Impact factor: 2.399

7.  The disease management program for type 2 diabetes in Germany enhances process quality of diabetes care - a follow-up survey of patient's experiences.

Authors:  Ingmar Schäfer; Claudia Küver; Benjamin Gedrose; Falk Hoffmann; Barbara Russ-Thiel; Hans-Peter Brose; Hendrik van den Bussche; Hanna Kaduszkiewicz
Journal:  BMC Health Serv Res       Date:  2010-03-03       Impact factor: 2.655

Review 8.  [New developments in retinal detachment surgery].

Authors:  U Bartz-Schmidt; P Szurman; D Wong; B Kirchhof
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

9.  [Blindness in Germany: dimensions and perspectives].

Authors:  R P Finger
Journal:  Ophthalmologe       Date:  2007-10       Impact factor: 1.059

10.  National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness.

Authors:  Marilyn D Farber
Journal:  Ophthalmic Epidemiol       Date:  2003-10       Impact factor: 1.648

View more
  5 in total

Review 1.  [Ophthalmology 2019-where do we stand? : An analysis of the treatment situation in Germany].

Authors:  Alexander K Schuster; Christian Wolfram; Norbert Pfeiffer; Robert P Finger
Journal:  Ophthalmologe       Date:  2019-09       Impact factor: 1.059

Review 2.  The Diagnosis and Treatment of Age-Related Macular Degeneration.

Authors:  Andreas Stahl
Journal:  Dtsch Arztebl Int       Date:  2020-07-20       Impact factor: 5.594

Review 3.  Markedly decreasing incidence of cause-specific blindness in Saxony (Eastern Germany).

Authors:  Heiner Claessen; Tatjana Kvitkina; Maria Narres; Christoph Trautner; Bernd Bertram; Andrea Icks
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-09-25       Impact factor: 3.117

Review 4.  Anti-VEGF therapies for age-related macular degeneration: a powerful tactical gear or a blunt weapon? The choice is ours.

Authors:  Paolo Lanzetta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-20       Impact factor: 3.117

5.  Progression to severe visual impairment and blindness in POAG patients: pace and risk factors-a cohort study using German health claims data.

Authors:  Sophia Nestler; Daniel Kreft; Gabriele Doblhammer; Rudolf F Guthoff; Stefanie Frech
Journal:  BMJ Open Ophthalmol       Date:  2022-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.